Arcutis Biotherapeutics, Inc. posts annual revenue of $3.69 million in 2022

Arcutis Biotherapeutics, Inc. [ARQT] has reported $311.46 million profit for the fiscal year ending Dec 31, 2022.

Revenue for the year was $3.69 million with operating income of $301.63 million.

The Westlakevillage, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $209.58 million.

Also read:

This is a developing story. Click here to receive updates.

------------

NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.